Bazedoxifene Does Not Adversely Affect Breast Tissue Density or Tenderness
This is a discussion on Bazedoxifene Does Not Adversely Affect Breast Tissue Density or Tenderness within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; The investigational agent bazedoxifene, a selective estrogen receptor modulator (SERM), plus conjugated estrogen (Wyeth's Women's HealthCare) has the ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
09-30-2008, 02:38 PM
|
|||
|
|||
Bazedoxifene Does Not Adversely Affect Breast Tissue Density or Tenderness
The investigational agent bazedoxifene, a selective estrogen receptor modulator (SERM), plus conjugated estrogen (Wyeth's Women's HealthCare) has the same effect as placebo in post-menopausal women.
Reuters Health Information More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Bone Mineral Density Decreased in Young Women With Type 1 Diabetes | industry_news | Other Clinical Pharmacy News | 0 | 09-02-2008 07:26 PM |
| Five-Year Intervals Recommended for Retesting Bone Density | industry_news | Other Clinical Pharmacy News | 0 | 08-07-2008 10:37 AM |
| Invitrogen gets breast cancer test approval | industry_news | Biotechnology News | 0 | 07-09-2008 05:59 PM |
| Wyeth gets approvable letter for bazedoxifene | industry_news | Biotechnology News | 0 | 05-23-2008 04:06 PM |
© 2008 DrugManagementForum™ powered by |
 |